Michael J. Absalon, MD, PhD

Cincinnati Children's Hospital Med. Ctr.
Cancer and Blood Diseases Institute
3333 Burnet Ave.
MLC 7018
Cincinnati, OH
USA 45229-3039
Papers:
336 A Phase I/Pilot Study of CPX-351 [Daunorubicin and Cytarabine Liposome for Injection (Vyxeos®)] for Children, Adolescents and Young Adults with Recurrent or Refractory Acute Leukemia